http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20220034725-A
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_14ff914f259bb631f31d4b32b1eaddd4 |
classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-32 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-4742 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-4712 |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-564 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-564 |
filingDate | 2020-05-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_98d3abe4c6a2baa516b734e4976007c2 |
publicationDate | 2022-03-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | KR-20220034725-A |
titleOfInvention | Detection of biomarkers associated with Brugada syndrome |
abstract | Methods are provided for detecting target autoantibodies to actin, connexin-43 and keratin in a mammal. The method comprises contacting a biological sample obtained from a mammal with each of actin, connexin-43 and keratin or an antigenic fragment thereof; and detecting the presence of the target autoantibody in the sample by detecting binding of the target autoantibody to the respective antigen. The method is useful for diagnosing Brugada syndrome. |
priorityDate | 2019-05-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 596.